1. Mortality and complications after treatment of acute diabetic Charcot foot.
- Author
-
Jansen RB, Jørgensen B, Holstein PE, Møller KK, and Svendsen OL
- Subjects
- Acute Disease, Adult, Aged, Arthropathy, Neurogenic complications, Arthropathy, Neurogenic epidemiology, Arthropathy, Neurogenic mortality, Denmark epidemiology, Diabetes Mellitus, Type 2 epidemiology, Diabetic Foot epidemiology, Diabetic Foot therapy, Diabetic Neuropathies complications, Diabetic Neuropathies epidemiology, Diabetic Neuropathies mortality, Female, Humans, Male, Middle Aged, Retrospective Studies, Wound Healing, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 mortality, Diabetic Foot complications, Diabetic Foot mortality
- Abstract
Aims: Charcot foot is a rare but disabling complication to diabetic neuropathy, and can cause permanent, limb-threatening deformities. The aim of this study was to investigate a population of patients a Charcot foot on a case-by-case basis, in order to assess the consequences of an acute Charcot foot and its complications., Methods: The study was conducted a retrospective study of patients admitted to the Copenhagen Wound Healing Center between 1996 and 2015 with the diagnosis of Charcot foot (DM14.6) and diabetes mellitus type 1 or 2 (DE10.X and DE11.X). Physical and electronic records were used, and compared to data from the Danish Diabetes Registry., Results: In total 392 patients were identified of which 173 were included. There were 26% with type 1 diabetes (initial HbA1c 81.7 ± 21.4 mmol/mol) and 74% with type 2 diabetes (initial HbA1c 66.5 ± 20.3 mmol/mol). Primary off-loading was with a removable walker in 95% of the cases (average off-loading time 8.3 months). The 5-year mortality was 14% with a mean survival time of 12.7 years. There was an association between lack of compliance and occurrence of foot complications, as well as between having a Charcot foot and leaving the workforce., Conclusion: More patients had type 1 diabetes compared to the background population, and they had a higher HbA1c than the general population of diabetes patients. A total of 67% developed complications such as ulcers, while patients non-compliant to treatment did significantly worse than those being compliant. The 5-year mortality was low, 14%, and comparable to diabetes patients without Charcot foot., (Copyright © 2018 Elsevier Inc. All rights reserved.) more...
- Published
- 2018
- Full Text
- View/download PDF